| |
|
|
| Name: |
BVF INC/IL |
| City: |
SAN FRANCISCO |
| State: |
CA |
| Zip: |
94104 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
42 |
|
View All Holdings |
Currently
Viewing:
Unchanged Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
MLTX |
Multisys Language Solutions... |
1 |
- |
$0.00 |
$1,092,567,000 |
21,751,284 |
30.04% |
-220,993,000 |
0 |
36.288 |
N/A |
|
|
KYMR |
Kymera Therapeutics, Inc. |
2 |
- |
$0.00 |
$207,504,000 |
5,161,801 |
5.7% |
76,085,000 |
0 |
8.28 |
N/A |
|
|
RVMD |
Revolution Medicines, Inc. |
3 |
- |
$40.68 |
$192,774,000 |
5,981,212 |
5.3% |
21,233,000 |
0 |
3.651 |
N/A |
|
|
GHRS |
Gh Research Ord Shs |
5 |
- |
$0.00 |
$110,866,000 |
10,400,158 |
3.05% |
50,545,000 |
0 |
21.29 |
N/A |
|
|
MIRM |
Mirum Pharmaceuticals, Inc. |
7 |
- |
$0.00 |
$109,775,000 |
4,370,024 |
3.02% |
-19,228,000 |
0 |
8.153 |
N/A |
|
|
IONS |
Ionis Pharmaceuticals Inc |
9 |
- |
$39.87 |
$105,280,000 |
2,428,613 |
2.89% |
-17,584,000 |
0 |
1.693 |
Drug Manufacturers - ... |
|
|
OLMA |
Olema Pharmaceuticals, Inc. |
10 |
- |
$0.00 |
$103,418,000 |
9,135,893 |
2.84% |
-24,759,000 |
0 |
16.578 |
N/A |
|
|
XOMA |
XOMA Corporation |
12 |
- |
$24.34 |
$87,392,000 |
3,633,743 |
2.4% |
20,168,000 |
0 |
32.243 |
Biotechnology |
|
|
EPIX |
ESSA Pharma Inc |
15 |
- |
$0.00 |
$74,276,000 |
8,748,629 |
2.04% |
16,535,000 |
0 |
19.892 |
Diagnostic Substances |
|
|
ZYME |
Zymeworks Inc |
16 |
- |
$8.92 |
$61,752,000 |
5,870,000 |
1.7% |
763,000 |
0 |
8.385 |
N/A |
|
|
CGEM |
Cullinan Oncology Ord Shs |
18 |
- |
$0.00 |
$54,472,000 |
3,196,701 |
1.5% |
21,898,000 |
0 |
7.345 |
N/A |
|
|
ANNX |
Annexon, Inc. |
21 |
- |
$0.00 |
$50,190,000 |
7,000,000 |
1.38% |
18,410,000 |
0 |
8.13 |
N/A |
|
|
RPTX |
Repare Therapeutics Inc. |
22 |
- |
$0.00 |
$48,671,000 |
10,333,600 |
1.34% |
-26,764,000 |
0 |
28.119 |
N/A |
|
|
ETNB |
89bio, Inc. |
23 |
- |
$8.07 |
$47,111,000 |
4,047,354 |
1.3% |
1,902,000 |
0 |
4.135 |
N/A |
|
|
SNDX |
Syndax Pharmaceuticals Inc |
24 |
- |
$19.21 |
$44,625,000 |
1,875,000 |
1.23% |
4,106,000 |
0 |
1.994 |
N/A |
|
|
ACIU |
AC Immune SA |
25 |
- |
$4.61 |
$43,131,000 |
14,571,236 |
1.19% |
-29,725,000 |
0 |
20.311 |
N/A |
|
|
THRD |
Third Harmonic Bio, Inc. |
26 |
- |
$13.74 |
$41,214,000 |
4,365,933 |
1.13% |
-6,680,000 |
0 |
10.769 |
N/A |
|
|
ENGN |
Engene Holdings Inc. |
27 |
- |
$7.95 |
$38,155,000 |
2,251,037 |
1.05% |
17,378,000 |
0 |
9.703 |
N/A |
|
|
NAMS |
Newamsterdam Pharma Ord Shs |
28 |
- |
$0.00 |
$35,994,000 |
1,521,948 |
0.99% |
18,994,000 |
0 |
1.866 |
N/A |
|
|
GPCR |
Structure Therapeutics Inc. |
29 |
- |
$56.30 |
$34,845,000 |
812,988 |
0.96% |
1,708,000 |
0 |
1.753 |
N/A |
|
|
ROIV |
Roivant Sciences Ltd. |
30 |
- |
$10.88 |
$28,905,000 |
2,742,409 |
0.79% |
-1,892,000 |
0 |
0.396 |
N/A |
|
|
GLYC |
Glycomimetics Inc |
31 |
- |
$0.27 |
$28,633,000 |
9,544,262 |
0.79% |
6,109,000 |
0 |
19.955 |
N/A |
|
|
TCRX |
Tscan Therapeutics, Inc. |
32 |
- |
$0.00 |
$23,736,000 |
2,989,474 |
0.65% |
6,307,000 |
0 |
6.864 |
N/A |
|
|
VSTM |
Verastem, Inc. |
34 |
- |
$3.79 |
$19,886,000 |
1,685,219 |
0.55% |
6,168,000 |
0 |
6.679 |
Biotechnology |
|
|
CALT |
Calliditas Therapeutics Ab |
35 |
- |
$0.00 |
$16,238,000 |
750,000 |
0.45% |
-3,090,000 |
0 |
3.004 |
N/A |
|
|
CTMX |
Cytomx Therapeutics, Inc. |
36 |
- |
$0.00 |
$14,379,000 |
6,595,801 |
0.4% |
4,156,000 |
0 |
10.123 |
N/A |
|
|
ELEV |
Elevation Oncology, Inc. |
37 |
- |
$3.72 |
$11,862,000 |
2,312,200 |
0.33% |
10,620,000 |
0 |
5.452 |
N/A |
|
|
VTGN |
Vistagen Therapeutics Inc |
40 |
- |
$3.90 |
$10,560,000 |
2,000,000 |
0.29% |
280,000 |
0 |
7.399 |
Biotechnology |
|
|
ELDN |
Eledon Pharmaceuticals Ord Shs |
41 |
- |
$2.84 |
$8,913,000 |
4,326,710 |
0.25% |
1,125,000 |
0 |
30.236 |
N/A |
|
|
VERV |
Verve Therapeutics, Inc. |
42 |
- |
$0.00 |
$8,632,000 |
650,000 |
0.24% |
-429,000 |
0 |
0.808 |
N/A |
|
|
IKNA |
Ikena Oncology, Inc. |
43 |
- |
$0.00 |
$6,772,000 |
4,769,164 |
0.19% |
-2,623,000 |
0 |
9.882 |
N/A |
|
|
CDTX |
Cidara Therapeutics, Inc. |
44 |
- |
$0.00 |
$6,312,000 |
6,861,127 |
0.17% |
864,000 |
0 |
15.615 |
N/A |
|
|
VIGL |
Vigil Neuroscience, Inc. |
45 |
- |
$0.00 |
$6,184,000 |
1,813,633 |
0.17% |
54,000 |
0 |
6.415 |
N/A |
|
|
KRON |
Kronos Bio, Inc. |
51 |
- |
$0.00 |
$3,777,000 |
2,905,043 |
0.1% |
146,000 |
0 |
5.185 |
N/A |
|
|
PIRS |
Pieris Pharmaceuticals, Inc. |
52 |
- |
$0.15 |
$3,776,000 |
20,609,863 |
0.1% |
25,000 |
0 |
36.823 |
N/A |
|
|
VIRX |
Viracta Therapeutics Ord Shs |
53 |
- |
$0.50 |
$3,687,000 |
3,614,662 |
0.1% |
1,627,000 |
0 |
9.746 |
Biotechnology |
|
|
IVA |
Inventiva Adr Representing ... |
54 |
- |
$3.60 |
$2,483,000 |
686,040 |
0.07% |
-590,000 |
0 |
1.787 |
N/A |
|
|
FBRX |
Forte Biosciences Inc |
55 |
- |
$1.26 |
$2,090,000 |
2,982,105 |
0.06% |
-360,000 |
0 |
8.206 |
N/A |
|
|
MOLN |
Molecular Partners Adr |
56 |
- |
$0.00 |
$1,720,000 |
443,221 |
0.05% |
-44,000 |
0 |
1.373 |
N/A |
|
|
NLSP |
Nls Pharmaceutics Ord Shs |
58 |
- |
$0.00 |
$1,045,000 |
5,747,126 |
0.03% |
-2,345,000 |
0 |
47.615 |
N/A |
|
|
ASLN |
Aslan Pharmaceuticals Ltd |
59 |
- |
$0.57 |
$646,000 |
1,049,999 |
0.02% |
98,000 |
0 |
0.807 |
N/A |
|
|
RZLT |
Rezolute, Inc |
61 |
- |
$5.79 |
$487,000 |
190,815 |
0.01% |
298,000 |
0 |
0.568 |
N/A |
|
